Ads
related to: bristol-myers squibbscbn.org has been visited by 10K+ users in the past month
Search results
Cancer biotech lays off more employees in 2024, begins hunt for 'strategic options' - Boston...
The Business Journals· 1 day agoFor the second time this year, Ikena Oncology is once again cutting its workforce and slimming down...
Is It Too Late to Buy Vertex Pharmaceuticals Stock? | The Motley Fool
The Motley Fool· 4 days agoVertex Pharmaceuticals (VRTX 1.36%) is a fast-growing pharmaceutical company that investors have...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 days agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Market Today: Prothena's Licensing Deal with Bristol Myers and E
Guru Focus· 2 days agoMarket Overview The stock market exhibited mixed action today. There wasn't a lot of conviction from...
Recursion Pharma Taps Hershberg as Next Chair to Succeed Chavez
Market Watch· 6 days agoRecursion Pharmaceuticals is naming a new chair as Martin Chavez departs after four years at the board's helm. The clinical stage biotechnology company said Friday that it has tapped Dr. Robert ...
10 Health Care Stocks With Whale Alerts In Today's Session - CVS Health (NYSE:CVS), Bristol-Myers...
Benzinga· 2 days agoLoading... Loading... This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga ...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 day agoNEWSPLUS The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0225 ET...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 4 days agoVertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates...
Biotech faces a reckoning: ‘We've lost our luster in cell therapies’
FierceBiotech· 1 day agoThis story is the first part in a four-part series about cell therapy, created by the Fierce Biotech...